Tag: labs

Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

 stock analyst  05/08/2024  0 Comments on Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

Dr Reddy\’s Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore.​​

 Posted in: U.S. stock market trends  Tagged: , ,

Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

 stock analyst  05/08/2024  0 Comments on Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

Dr Reddy\’s Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore.​​

 Posted in: U.S. stock market trends  Tagged: , ,

Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

 stock analyst  05/08/2024  0 Comments on Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

Dr Reddy\’s Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore.​​

 Posted in: U.S. stock market trends  Tagged: , ,

Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

 stock analyst  05/08/2024  0 Comments on Dr Reddy\’s Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share

Dr Reddy\’s Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore.​​

 Posted in: U.S. stock market trends  Tagged: , ,

Goldman picks 2 pharma stocks, screams sells on Laurus Labs

 stock analyst  04/12/2024  0 Comments on Goldman picks 2 pharma stocks, screams sells on Laurus Labs

Global broking firm Goldman Sachs on Friday initiated coverage on Syngene International and Neuland Labs with buy ratings but gave a sell call on Laurus Labs.

 Posted in: u.s. stock index  Tagged: , , , , , , , , , , ,